Normal function · from ai-gene-review (P50995, commit 79fe13b38970) · AI-generated, not KB evidence

Annexin A11 is a calcium-responsive, peripheral phospholipid-binding protein with a long low-complexity N-terminal region and a C-terminal annexin-repeat domain. It associates dynamically with nuclear, cytoplasmic and membrane compartments, forms condensates, and couples ribonucleoprotein granules to lysosomal membranes. ALG-2 and S100A6 modulate its membrane-associated condensates, and it recruits sorcin to damaged plasma membrane during repair. In dividing human cells it is a stable component of the midbody and contributes to completion of cytokinesis. Pathogenic ANXA11 variants are associated with amyotrophic lateral sclerosis and can perturb protein assembly and intracellular trafficking.

Calcium-dependent peripheral phospholipid binding enables regulated association with cellular membranes.
Connects protein-containing ribonucleoprotein granules to lipid membranes through coordinated granule association and phospholipid binding; this membrane-adaptor activity is also demonstrated for sorcin recruitment.
Contributes to the stable midbody matrix during terminal cytokinesis in human cells; its molecular mechanism in this structure remains unresolved.
directly involved in: cytokinetic process · locations: midbody
In the knowledge base · computed from kb/ at build time

Disorders

Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.

DisorderRelationshipWhere the gene appears
Amyotrophic Lateral Sclerosis causative
mechanism: Vesicular and Endolysosomal Trafficking Failure
subtype: ALS23
scoped to subtype: ALS23
Neurosarcoidosis susceptibility germline
Sarcoidosis untyped
Susceptibility
ClinGen gene–disease validity · snapshot 2026-10-03 · matched to entries by MONDO

An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.

ClinGen diseaseMOIClassificationdismech entry
amyotrophic lateral sclerosis type 23 MONDO:0027694 AD Definitive
2021-11-12

Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.